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population of patients with knee pain
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Abstract
Background: The ICECAP measures potentially offer a broader assessment of quality of life and well-being, in
comparison to measures routinely used in economic evaluation, such as the EQ-5D-3 L. This broader assessment
may allow measurement of the full effects of an intervention or treatment. Previous research has indicated that the
ICECAP-O (for older people) and EQ-5D-3 L measure provide complementary information. This paper aims to determine
similar information for the ICECAP-A (for the entire adult population) in terms of whether the measure is a substitute or
complement to the EQ-5D-3 L.
Methods: Data from the BEEP trial - a multi-centre, pragmatic, randomised controlled trial - were used. Spearman rank
correlations and exploratory factor analytic methods were used to assess whether ICECAP-A and EQ-5D-3 L are measuring
the same, or different, constructs.
Results: A correlation of 0.49 (p < 0.01) was found between the ICECAP-A tariff score and the EQ-5D-3 L index. Using the
pooled items of the EQ-5D-3 L and the ICECAP-A a two factor solution was optimal, with the majority of EQ-5D-3 L items
loading onto one factor and the majority of ICECAP-A items onto another.
Conclusion: The results presented in this paper indicate that ICECAP-A and EQ-5D-3 L are measuring two different
constructs and provide largely different, complementary information. Results showed a similarity to results presented by
Davis et al. using the ICECAP-O.
Trial registration: ISRCTN 93634563
Background
The ICECAP-A and the ICECAP-O are two relatively
new patient reported outcome measures of wellbeing.
Both measures have value weighted tariffs attached, so
may be appropriate for use in economic evaluation, as
well as in evaluations of the effectiveness of an interven-
tion. These measures have their theoretical underpinnings
in Amartya Sen’s work on functioning and capability [1],
which advocates an assessment of wellbeing that maintains
a focus on what a person is able to do (capability), rather
than what a person does (functioning). The capability
approach encourages a broad evaluative space which can
include a person’s ability to achieve their basic require-
ments, such as living in good health, and more complex
abilities, such as the ability to achieve things that are
important to them, like fulfilling social or professional
roles [1].
The ICECAP-A is intended for use with adults, with a
sister measure (the ICECAP-O) available for use with
older people. The ICECAP-A measures capability in
Attachment, Stability, Achievement, Enjoyment and
Autonomy [2] (while the ICECAP-O measures capability
in Attachment, Security, Role, Enjoyment and Control
[3]). A score of one on both ICECAP measures indicates
full capability and the measures are anchored to “no
capability” indicated by a score of 0. Scores can be used
in economic evaluations through the use of full capabil-
ity [4] or sufficient capability [5] approaches.
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The most commonly used measure within economic
evaluations, in contrast, is a generic preference based
outcome focusing on health-related quality of life [6].
The descriptive system for this measure, the EQ-5D-3 L,
comprises mobility, self-care, usual activities, pain and
discomfort, and anxiety and depression [7]. The three
level version, the EQ-5D-3 L has been extensively vali-
dated in numerous clinical settings [8–11]. A score of
one indicates full health and states worse than death are
represented by scores between zero and−0.59. Scores
from the EQ-5D-3 L are used in economic evaluation
through the calculation of the quality-adjusted life year
[12]. The five level version of the EQ-5D was not avail-
able for use at the start of this trial.
The broader assessment of quality of life potentially
offered by the ICECAP-A may allow researchers to
assess changes in attributes that are not routinely evalu-
ated [13–15]. The ICECAP-A is being used alongside
the EQ-5D-3 L in a number of studies [16–18]. If the
ICECAP-A assesses additional attributes not measured
by the EQ-5D-3 L, then a strong case can be made for
using both measures in tandem (especially if the inter-
vention being tested targets attributes measured by the
ICECAP-A). However, if the ICECAP-A provides little
additional information, then use of multiple instruments
in research studies may be counter-productive, as it will
increase patient burden, increase the potential for select-
ive reporting [19, 20] and thus may lead to problems in
synthesis of evidence at later stages [21]. Determining which
of these potential situations is the case for ICECAP-A is
therefore important, and provides the focus for this research.
The results will help to determine the additional benefit of
including the ICECAP-A in empirical work, including eco-
nomic evaluation.
Earlier work, using exploratory factor analysis, deter-
mined that the ICECAP-O and EQ-5D-3 L provided
“largely unique and complementary information so are
not substitutes” p.975 [22]. Results indicated that the
ICECAP-O items of Attachment, Security, Role and
Enjoyment and the EQ-5D-3 L item of anxiety/depression
represented a single factor which the authors termed “psy-
chological well-being”. The EQ-5D-3 L items of mobility,
self-care, usual activities and pain represented a single
factor termed “physical functioning”. While they are simi-
lar measures, it cannot be assumed these results for the
ICECAP-O will hold for the ICECAP-A. Using factor
analytic methods, which are similar to the methodology
used by Davis et al. [22], we aim to assess whether the
ICECAP-A measure is a complement or substitute for the
EQ-5D-3 L.
Methods
This analysis was completed using data from the Benefits
of Effective Exercise for knee Pain (BEEP) trial, a primary
care, multi-centre, pragmatic randomised controlled trial
in the UK. This trial aimed to compare improvement in
pain and function outcomes from three physiotherapy-led
exercise interventions for older adults with knee pain
attributable to osteoarthritis [23]. The ICECAP-A and
EQ-5D-3 L were administered and baseline data are
used in this analysis.
Association
Spearman’s rank correlation was used to assess associ-
ation between the ICECAP-A tariff scores [24] and the
index scores of the EQ-5D-3.
Exploratory factor analysis
Exploratory factor analysis is a statistical technique
based on the premise that a battery of questions can be
described based on a smaller number of underlying
factors. Factor analysis describes variability amongst a
number of variables or items through the use of a smaller
number of unobserved variables, known as factors [25]. If
a scale is uni-dimensional then one factor should explain
the variance accurately [25]. Factor analysis can also be
used to test the assumption that a pool of items assesses
different underlying factors.
Exploratory factor analysis assumes that variables are
continuous and follow a normal distribution. When
using categorical variables, exploratory factor analysis
can be performed using polychoric correlations, which
are suitable for categorical variables or variables that do
not follow normal distribution. The number of factors
retained was chosen with reference to the Kaiser Criterion
[26], which advocates retaining factors with Eigen Values
greater than one and using the scree plot to assess the suit-
ability of this choice. An oblique Promax rotation was used,
which allows for the potential that factors are correlated.
Correlations between factors equal to or greater than 0.32
is considered the point at which oblique rotations are
appropriate [27]. Exploratory factor analysis was ap-
plied to all items from both the EQ-5D-3 L (5 items)
and the ICECAP-A (5 items).
Results
The characteristics of the BEEP trial participants used in
this analysis are presented in Table 1. The mean age of
participants was 63, with a roughly equal proportion of
male and female participants. The average ICECAP-A
capability tariff values were higher (indicating higher
capability) at baseline than values previously reported in
the general population [28]. Participants reported mean
EQ-5D-3 L scores at baseline that were lower than the
UK national average for this age group, indicating poorer
health-related quality-of-life [6] Other outcome mea-
sures indicated that this was a population with low levels
of anxiety and depression and moderate levels of pain
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and physical disability. A complete case analysis was per-
formed, which included all participants who completed
both the ICECAP-A and EQ-5D measures at baseline.
The ICECAP-A had a 99 % completion rate and the EQ-
5D-3 L has a 97 % completion rate, resulting in this fac-
tor analysis being completed using 442 participants.
Correlation
A moderate correlation of 0.49 (p < 0.01) was found
between the ICECAP-A tariff score and the EQ-5D
index. The scree plot showed a cluster of participants
scoring above 0.6 on the EQ-5D and above 0.8 on the
ICECAP-A (Fig. 1).
Exploratory factor analysis
The results of the exploratory factor analysis are pre-
sented in Table 2. Through consideration of a scree plot
and the number of Eigen Values greater than one, a two
factor solution was found to be optimal. The choice of
an oblique promax rotation was explored through use of
the STATA “estat common” command (post rotation).
This indicated a correlation of−0.52 between the factors,
indicating that an oblique promax rotation was an ap-
propriate choice for the analysis.
Table 2 shows a two factor solution indicating that two
separate, but correlated factors are assessed by the pooled
items of EQ-5D-3 L and the ICECAP-A. The majority of
EQ-5D-3 L items (Mobility, Self-care, Usual Activities and
Pain) loaded strongly onto factor two, while the majority
of ICECAP-A items (Stability, Attachment, Achievement,
Enjoyment) loaded onto factor one. The EQ-5D-3 L item
of Anxiety and Depression loaded strongly onto factor
one and the loading of Autonomy split, with moderate
loadings onto both factors.
Discussion
The results presented in this paper indicate that the
ICECAP-A and EQ-5D-3 L are measuring two different
constructs and therefore provide largely different infor-
mation. Results showed a strong similarity to results pre-
sented by Davis et al. [22] using the ICECAP-O.
The two factor solution found that the majority of
ICECAP-A items loaded onto one factor and the major-
ity of EQ-5D-3 L items onto another. The exception to
this was the EQ-5D-3 L item of anxiety and depression,
which loaded onto a factor with Stability, Attachment,
Achievement and Enjoyment. The Autonomy item loaded
moderately onto both factors. The Autonomy item assesses
a similar attribute to the Control item in the ICECAP-O,
which Davis et al. found to split between the two factors.
This analysis was completed in an older population with
higher capability scores than the general public, with
worse than average health states, therefore caution should
be exercised when generalising these results to the general
population, other patient groups or groups of different
Table 1 baseline characteristics
Characteristic Mean values (SD) Median values (IQR) Measure range Sample range Sample size
Socio-demographic
Age (SD) 63.3 (9.9) 45 to 90 456
Gender (% male) 50.2 %a 456
Health and functioning
ICECAP-A tariff 0.88 (0.12) 0.91 (0.85, 0.97 0.0 to 1.0 0.34 to 1.0 452
EQ-5D-3 L index 0.63 (0.24) 0.69 (0.62, 0.76) −0.59 to 1.0 −0.18 to 1.0 442
WOMAC painb 8.5 (3.5) 8 (6, 11) 0 to 20 0 to 18 449
WOMAC stiffness 3.8 (1.7) 4 (3, 5) 0 to 8 0 to 8 451
WOMAC functioning 28.7 (12.2) 27 (20, 37) 0 to 68 0 to 62 446
GAD-7c 3.4 (4.7) 1 (0, 4) 0 to 21 0 to 21 439
PHQ-8d 4.1 (4.8) 2 (1, 5) 0 to 24 0 to 24 442
aNot a mean value. bWOMAC (Western Ontario and McMaster Universities Osteoarthritis Index). cGAD-7 (General Anxiety Disorder-7) is a measure of anxiety.
dPHQ-9 (Patient Health Questionnaire-9) is a measure of depression
Fig. 1 ICECAP-A and EQ-5D scores, data points weighted by
frequency count
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ages. However, the analysis is consistent with previous
work on the ICECAP-O and EQ-5D-3 L which also sug-
gested that the ICECAP-O and EQ-5D-3 L are measuring
two separate, but correlated factors [22]. A further limita-
tion was the lack of availability of the EQ-5D-5 L at the
start of the BEEP trial. However, the descriptive systems of
both the three and five level measures comprise the same
five dimensions and considering the results of the EQ-5D
crosswalk study [29], one may cautiously expect similar
results using the EQ-5D-5 L.
Davis et al. have previously suggested that these factors
be termed “physical functioning” and “psychosocial well-
being”. We suggest that “physical health” and “wellbeing”
may be more reflective of how these constructs are
normally termed in health economic evaluation and in
academic literature. This change in terminology from
that suggested by Davis et al. was based on three lines of
thought. First, the EQ-5D and other similar measures
are conceptually focused on measuring health gain
(rather than functioning), as the primary focus of eco-
nomic evaluation. The findings of this work and to a
large extent the Davis work was that the physical as-
pects of EQ-5D loaded onto one factor, hence physical
health. Second, functioning as a term has a specific
meaning in relation to the capability approach (which
classifies outcomes in terms of functionings and cap-
abilities, related to whether people do these things or
are just able to do them; EQ-5D expresses one of its
dimensions as ability to conduct usual activities and
hence to refer to this as a functioning is potentially
confusing from a capability perspective) and using it
in this way could cause conceptual confusion. Third, it
is not clear that all aspects captured by the second factor
are ‘psychosocial’ particularly in relation to achievement
and autonomy (the latter of which loaded onto both fac-
tors); wellbeing, as a broader concept, seems to more accur-
ately capture the nature of the totality of attributes included
in the factor.
Conclusion
In conclusion, results presented in this paper indicate that
the ICECAP-A and EQ-5D-3 L are largely measuring two
different constructs and thus can be seen as complemen-
tary measures, rather than substitutes for one another.
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